Deutsche Bank
KRON

Deutsche Bank’s Kronos Bio KRON Stock Holding History

Deutsche Bank’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,423
Closed -$26.5K – 3765
2023
Q2 		$26.5K Sell
15,423
-34,024
-69% -$54K ﹤0.01% 3550
2023
Q1 		$72.2K Sell
49,447
-67,354
-58% -$129K ﹤0.01% 3446
2022
Q4 		$189K Buy
116,801
+272
+0.2% +$626 ﹤0.01% 3008
2022
Q3 		$391K Sell
116,529
-26,501
-19% -$120K ﹤0.01% 2523
2022
Q2 		$520K Buy
143,030
+21,051
+17% +$95.4K ﹤0.01% 2570
2022
Q1 		$882K Sell
121,979
-2,498
-2% -$21.3K ﹤0.01% 2431
2021
Q4 		$1.69M Buy
124,477
+101,630
+445% +$1.59M ﹤0.01% 2092
2021
Q3 		$479K Sell
22,847
-719
-3% -$15.4K ﹤0.01% 3068
2021
Q2 		$564K Buy
23,566
+13,684
+138% +$346K ﹤0.01% 3147
2021
Q1 		$289K Sell
9,882
-869
-8% -$25.5K ﹤0.01% 3433
2020
Q4 		$321K Buy
+10,751
New +$337K ﹤0.01% 3188

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank's KRON Position: Q3 2023 in Review

Deutsche Bank sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 15,423 shares — an estimated $26.5K sold.

Deutsche Bank first reported a position in KRON in Q4 2020 and held it in 11 quarters. The position peaked at $1.69M in Q4 2021. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

  • Deutsche Bank reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
  • Deutsche Bank sold 15,423 Kronos Bio shares in Q3 2023, an estimated $26.5K.
  • Deutsche Bank first reported a position in Kronos Bio in Q4 2020 and held it in 11 quarters.
  • Deutsche Bank's Kronos Bio position peaked at $1.69M in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.